Virtus Health (VRT.AX) Stock Price
Virtus Health Price
Over the last 12 years Virtus Health grew revenue by 13.8% annually, reaching 324.60 M AUD. Earnings per share have grown at 20.3% per year over the last 12 years. For Virtus Health, the net margin of 13.3% is up versus 11.0% a few years ago. The payout ratio is around 64% of earnings.
Virtus Health stock price
Virtus Health business model & stock analysis
Frequently asked questions about Virtus Health
Virtus Health Ltd operates with an innovative business model in the reproductive healthcare industry. As a leading provider of fertility services, Virtus Health offers a comprehensive range of assisted reproductive technology (ART) solutions. The company conducts fertility assessments, consultations, and diagnostics, providing individuals and couples with personalized treatment plans to optimize their chances of starting a family. With a network of fertility clinics and laboratories, Virtus Health offers services like in vitro fertilization (IVF), egg freezing, donor programs, and preimplantation genetic testing. The company's business model focuses on delivering high-quality fertility care, promoting patient-centric approaches, and leveraging cutting-edge ART techniques to support individuals and families on their unique fertility journeys.
Virtus Health Ltd is primarily active in the healthcare industry.
The main competitors of Virtus Health Ltd in the market include Monash IVF Group Limited, Primary Health Care Limited, and Genea Limited.
Virtus Health Ltd is an Australian healthcare company that specializes in assisted reproductive services. Established in 2008, Virtus Health has a rich history of providing high-quality fertility treatments and comprehensive care to patients. With a focus on innovation and patient-centered approach, Virtus Health has become a trusted name in the reproductive medicine field. The company is renowned for its state-of-the-art laboratories, cutting-edge technologies, and experienced team of fertility specialists. With a commitment to helping individuals and couples achieve their dream of parenthood, Virtus Health continues to lead the way in the field of assisted reproductive services.
Virtus Health Ltd, a leading fertility services organization, has achieved significant milestones in its journey. The company has successfully expanded its presence globally, with over 130 fertility clinics across Australia, Ireland, Denmark, and Singapore. Moreover, Virtus Health has consistently demonstrated exceptional fertility success rates, offering hope and fulfilling the dreams of thousands of couples worldwide. The company remains at the forefront of reproductive medicine, prioritizing the latest technologies and advancements to deliver superior patient outcomes. With its strong reputation for excellence and dedication to helping individuals build families, Virtus Health Ltd continues to solidify its position as a trusted and respected leader in the field of reproductive healthcare.
Virtus Health Ltd is primarily present in Australia, where it operates a network of fertility clinics. As the leading fertility service provider in the country, Virtus Health has a strong presence across major cities such as Sydney, Melbourne, Brisbane, Adelaide, and Perth. Additionally, Virtus Health has expanded its operations internationally and currently has fertility clinics in Singapore, Ireland, Denmark, and the United Kingdom. With its widespread presence, Virtus Health continues to provide high-quality fertility services and support to patients in multiple countries and regions.
Virtus Health Ltd represents a set of core values and corporate philosophy that define its operations. Committed to excellence in reproductive healthcare, Virtus Health values compassion, integrity, and innovation. By placing patients and their needs at the forefront, the company strives to deliver high-quality fertility services and support throughout their journey. With a focus on clinical excellence and continuous improvement, Virtus Health aims to provide advanced reproductive technology and personalized care. The company's commitment to research and collaboration further enhances its mission to help couples and individuals achieve their dream of starting a family. Through these values and philosophy, Virtus Health Ltd sets itself apart in the field of reproductive healthcare.
7 analysts currently rate the Virtus Health stock: 0 recommend buying, 3 holding and 4 selling.
The Virtus Health share (VRT.AX) is listed on 2 stock exchanges, including: NYSE (ZTR), Frankfurt (V6H.F).
Virtus Health Ltd is a globally leading provider of fertility solutions. The company is headquartered in Sydney, Australia, and operates over 90 clinics in Australia, New Zealand, Ireland, Singapore, and Denmark, as well as numerous partnerships in other countries. The company was founded in 2008 and listed on the Australian stock exchange the same year. Virtus Health's business model is to offer comprehensive fertility services, such as assisted reproductive technologies (ART), including in-vitro fertilization (IVF), intrauterine insemination (IUI), egg donation, sperm donor provision, pre-implantation diagnostics (PID), and andrology services including investigation and treatment of male infertility. The company is divided into several divisions. The main divisions are Australia and New Zealand, Europe, and Asia. Many of its customer groups are women who have difficulty getting pregnant or couples who have difficulty conceiving. The company also offers services for same-sex couples, who can work with some of the best fertility experts. Virtus Health works closely with doctors, medical professionals, and health organizations to ensure the highest standards in fertility medicine. The company also provides comprehensive patient care, including a range of programs to support the mental health of patients and families during the IVF process. The company also owns the cryogenic biobank program, a storage network for embryos and eggs that are not immediately used for IVF, as well as a comprehensive sperm bank for donor sperm. In addition, Virtus Health offers a range of online tools for women trying to conceive, such as ovulation computers that can help determine the optimal time for intercourse to conceive a baby. Overall, Virtus Health's business model is aimed at helping couples around the world fulfill their desire for a family and providing them with an excellent customer experience. In the future, Virtus Health will continue to invest in new technologies, such as Mini-IVF, to better support its customers in addressing fertility issues.
The revenue cannot currently be calculated for Virtus Health.
The profit cannot currently be calculated for Virtus Health.
The P/E ratio cannot be calculated for Virtus Health at the moment.
The P/S cannot be calculated for Virtus Health currently.
The Eulerpool Quality Score for Virtus Health is 6/10.
The ISIN of Virtus Health is AU000000VRT3. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The WKN of Virtus Health is A1WZJU. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.
The ticker of Virtus Health is VRT.AX. The ticker symbol is used to trade Virtus Health shares on the stock exchange.
The current dividend yield of Virtus Health is - %.
Virtus Health is assigned to the 'Health' sector.
In the year 2021, Virtus Health distributed 0.34 AUD as dividends.
The dividends of Virtus Health are distributed in AUD.
Virtus Health stock
Virtus Health Peer Group
Virtus Health Ticker
Virtus Health FIGI
All fundamentals and in-depth analysis of Virtus Health
Our stock analysis for Virtus Health stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Virtus Health. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.